Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026| (NASDAQ: XERS) | Delayed: 8.16 +0.38 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.78 | 52 Week High | $ | |||
| Open | $7.68 | 52 Week Low | $ | |||
| Day High | $8.18 | P/E | N/A | |||
| Day Low | $7.69 | EPS | $ | |||
| Volume | 2,341,272 | |||||

